Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987961 · ClinicalTrials.gov registry record · Phase 3
Linking Hospitalized Injection Drug Users to Buprenorphine
A Phase 3 study of Opiate Dependence, sponsored by Butler Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 147
- Enrollment target
- 1
- Study location
NCT00987961: Completed Phase 3 study of Opiate Dependence, sponsored by Butler Hospital.
NCT00987961 is a Phase 3 study of Opiate Dependence that has completed, run by Butler Hospital. The registered enrollment target is 147 participants, below the 598-participant average among 15 other Opiate Dependence trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00987961, a Phase 3 study of Opiate Dependence, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 147 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests whether starting Suboxone (buprenorphine) during a medical hospitalization, and then providing an appointment (a "link") for after discharge to maintenance buprenorphine in an outpatient setting will reduce HIV risk behavior in individuals who inject opioids.
Conditions Studied
Interventions
- BEHAVIORAL Linkage
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 147 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-09 |
| Phase | Phase 3 |
What the finished NCT00987961 record still lists
NCT00987961 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 598-participant average among 15 other Opiate Dependence trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Opiate Dependence appearing as the primary indexed condition, and to 1 intervention - of which Linkage is the first listed.
NCT00987961 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00987961 about?
NCT00987961 is a clinical study titled "Linking Hospitalized Injection Drug Users to Buprenorphine". This study tests whether starting Suboxone (buprenorphine) during a medical hospitalization, and then providing an appointment (a "link") for after discharge to maintenance buprenorphine in an outpatient setting will reduce HIV risk behavior in individuals who inject opioids.
What is the current status of trial NCT00987961?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 147 participants. The study started on 2009-09. Estimated completion is 2015-09.
What conditions does trial NCT00987961 study?
This clinical trial studies the following conditions: Opiate Dependence.
What interventions are being tested in trial NCT00987961?
The interventions under investigation include: Linkage (BEHAVIORAL).
Who is sponsoring clinical trial NCT00987961?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00987961 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00987961's enrollment target sits among peer trials
147 5th of 15 higher than 11 of 15 other Opiate Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opiate Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
COMPLETED · Phase 3
-
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
COMPLETED · Phase 3
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
-
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04396613 · 147 participants · NA
Wound Closure Techniques in Primary Spine Surgery
- NCT04851119 · 147 participants · Phase 1
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NCT05523947 · 147 participants · Phase 1
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
- NCT06121843 · 147 participants · Phase 1
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia